Dr. Hattangadi-Gluth is Central Nervous System (CNS) Tumor Section Chief as well as Associate Director for Imaging Research in the Division of Clinical & Translational Research. She oversees a research lab within the Center for Translational Radiation Medicine & Imaging (CTRMI) within the Altman Clinical & Translational Research Institute.
A nationally-recognized expert in the treatment of patients with brain tumors, she serves on the National Comprehensive Cancer Network (NCCN) panel for the treatment of CNS malignancies. Her research focuses on the use of advanced magnetic imaging (MRI) techniques in radiation therapy planning and measuring response to radiation in brain tissue. A holder of multiple grants, she is the principal investigator on several investigator-initiated clinical trials, including a longitudinal study of advanced diffusion imaging and serial neurocognitive testing to measure radiation-induced injury in brain tumor patients. In addition to her imaging research, she is also active in Health Outcomes research and has published studies on a wide range of topics including medical device recalls, industry payments to physicians and medical malpractice claims, which have appeared in many prestigious journals including the Journal of the American Medical Association (JAMA).